Maartje W. Rohaan

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Phenotypic and Functional Characteristics of CD8+ T Cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.

Phenotypic and Functional Characteristics of CD8+ T Cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 27, 2025

NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy.

NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy.

Journal: Nature communications

Published: June 05, 2025

The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanoma.

The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 31, 2025

Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.

Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial.

Journal: The British journal of surgery

Published: December 24, 2024

Art of TIL immunotherapy: SITC's perspective on demystifying a complex treatment.

Art of TIL immunotherapy: SITC's perspective on demystifying a complex treatment.

Journal: Journal for immunotherapy of cancer

Published: December 03, 2024

Health-related quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared with ipilimumab in a randomized phase III trial.

Health-related quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared with ipilimumab in a randomized phase III trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 11, 2024

Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis.

Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 28, 2024

Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial.

Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial.

Journal: Journal for immunotherapy of cancer

Published: February 26, 2024

Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial.

Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial.

Journal: Oncology research and treatment

Published: December 14, 2023

Clinical presentation of cardiac symptoms following treatment with tumor-infiltrating lymphocytes: diagnostic challenges and lessons learned.

Clinical presentation of cardiac symptoms following treatment with tumor-infiltrating lymphocytes: diagnostic challenges and lessons learned.

Journal: ESMO open

Published: September 14, 2023

"One more chance to survive": the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy-a qualitative study and recommendations for future care.

"One more chance to survive": the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy-a qualitative study and recommendations for future care.

Journal: Journal of cancer survivorship : research and practice

Published: March 14, 2023

Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma. Reply.

Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma. Reply.

Journal: The New England journal of medicine

Published: March 01, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026